Guidelines for the control of glycopeptide-resistant enterococci in hospitals

Journal of Hospital Infection

Volumn 62, Issue 1, 2006, Pages 6-21

  Cookson, B D ^a   Macrae, Bruce M ^b,j   Barrett, S P ^c   Brown, D F J ^d   Chadwick, C ^e   French, G L ^f   Hateley, P ^g   Hosein, I K ^h   Wade, J J ⁱ  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e CHRISTIE HOSPITAL   (United Kingdom)

^f ST THOMAS HOSPITAL   (United Kingdom)

^g ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^h CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

ⁱ KING S COLLEGE HOSPITAL   (United Kingdom)

^j Windeyer Institute   (United Kingdom)

more..

Author keywords

Glycopeptide resistant enterococci; GRE; Guidelines; Hospital infection; Infection control

Indexed keywords

ALCOHOL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFTAZIDIME; CEPHALOSPORIN; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; CHLORINE; DALFOPRISTIN PLUS QUINUPRISTIN; LINEZOLID; METRONIDAZOLE; NALIDIXIC ACID; OXAZOLIDINEDIONE DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; POLYPEPTIDE ANTIBIOTIC AGENT; POVIDONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SODIUM AZIDE; STREPTOGRAMIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL INFECTION; DIARRHEA; ENTEROCOCCUS; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; PERSONAL HYGIENE; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEPSIS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; GLYCOPEPTIDES; GRAM-POSITIVE BACTERIAL INFECTIONS; HOSPITALS; HUMANS; INFECTION CONTROL; VANCOMYCIN RESISTANCE;

EID: 30844457272     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2005.02.016     Document Type: Review

References (133)

1. Hospital Infection Control Practices Advisory Committee Recommendations for preventing the spread of vancomycin resistance Infect Control Hosp Epidemiol 16 1995 105-113
2. G.A.J. Ayliffe M.W. Casewell B.D. et al. Cookson Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. Report of a Combined Working Party of the British Society for Antimicrobial Chemotherapy, the Hospital Infection Society and the Infection Control Nurses Association J Hosp Infect 39 1998 253-290
3. M. Egger S.G. Davey D. Altman Systematic reviews in health care 2001 BMJ Publications London
4. R. Harbour J. Miller for the Scottish Intercollegiate Guidelines Network Grading Review Group A new system for grading recommendations in evidence based guidelines BMJ 323 2001 334-336
5. G. Waddell G. Feder A. McIntosh et al. Clinical guidelines for management of low back pain (low back pain evidence review) 1996 Department of Health London p. 36
6. R.J. Pratt C. Pellowe H.P. Loveday et al. The epic project: Developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: Guidelines for preventing hospital-acquired infections. Department of Health (England) J Hosp Infect 47 Suppl 2001 S3-S82
7. J.M. Stuart A.B. Gilmore A. Ross et al. Preventing secondary meningococcal disease in health care workers: Recommendations of a working group of the PHLS meningococcus forum Commun Dis Public Health 4 2001 102-105
8. B.S. Cooper S.P. Stone C.C. Kibbler et al. The hospital management of methicillin-resistant Staphylococcus aureus: A review of the literature with epidemiological and economic modelling Health Technol Assess 7 2003 1-194
9. S. Harbarth S. Cosgrove Y. Carmeli Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci Antimicrob Agents Chemother 46 2002 1619-1628
10. G.C. Mead Streptococci in the intestinal flora of man and other non-ruminant animals F.A. Skinner L.B. Quesnel Streptococci 1978 Academic Press London 245-261
11. C.J. Noble Carriage of group D streptococci in the human bowel J Clin Pathol 31 1978 1182-1186
12. L.M. Teixeira R.R. Facklam Enterococcus P.R. Murray E.J. Baron M.A. Jorgensen Manual of clinical microbiology 8th ed 2003 American Society of Microbiology Washington, DC 422-433
13. B.E. Murray The life and times of the enterococcus Clin Microbiol Rev 3 1990 46-65
14. R.C. Moellering Emergence of enterococcus as a significant pathogen Clin Infect Dis 14 1992 1173-1176
15. D.R. Schaberg D.H. Culver R.P. Gaynes Major trends in the microbial etiology of nosocomial infection Am J Med 91 Suppl 3B 1991 S72-S75
16. B.D. Cookson D. Morrison R.R. Marples Antibiotic resistance. Nosocomial Gram positive infection J Med Microbiol 6 1997 439-442
17. P.E. Coudron C.G. Mayhall R.R. Facklam et al. Streptococcus faecium outbreak in a neonatal intensive care unit J Clin Microbiol 20 1984 1044-1048
18. M.J. Zervos C.A. Kauffman P.M. Therasse et al. Nosocomial infection by gentamicin-resistant Streptococcus faecalis-an epidemiologic study Ann Int Med 106 1987 687-691
19. M.J. Zervos M.S. Terpenning D.R. Schaberg et al. High-level aminoglycoside-resistant enterococci-colonization of nursing home and acute care hospital patients Arch Intern Med 147 1987 1591-1594
20. E. Rhinehart N.E. Smith C. Wennersten et al. Rapid dissemination of β-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward N Engl J Med 323 1990 1814-1818
21. J.C. Barna D.H. Williams The structure and mode of action of glycopeptide antibiotics of the vancomycin group Ann Rev Microbiol 34 1984 339-357
22. R. Nagarajan Antibacterial activities and modes of action of vancomycin and related glycopeptides Antimicrob Agents Chemother 35 1991 605-609
23. P.E. Reynolds Structure, biochemistry and mechanism of action of glycopeptide antibiotics Eur J Clin Microbiol Infect Dis 8 1989 943-950
24. P.E. Reynolds Glycopeptide resistance in Gram-positive bacteria J Med Microbiol 36 1992 14-17
25. N. Woodford A.P. Johnson D. Morrison et al. Current perspectives on glycopeptide resistance Clin Microbiol Rev 8 1995 585-615
26. R. Leclerq P. Courvalin Resistance to glycopeptides in enterococci Clin Infect Dis 24 1997 545-556
27. Y. Cetinkaya P. Falk C.G. Mayhall Vancomycin-resistant enterococci Clin Microbiol Rev 13 2000 686-707
28. S. Evers B. Casadewall M. Charles et al. Evolution of structure and specificity in D-alanine: D-alanine ligases and related enzymes J Mol Evol 42 1996 706-712
29. W.C. Noble Z. Virani R.G.A. Cree Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus FEMS Microbiol Lett 93 1992 195-198
30. Centers for Disease Control and Prevention Staphylococcus aureus resistant to vancomycin-United States, 2002 MMWR 51 2002 565-567
31. Centers for Disease Control and Prevention Staphylococcus aureus resistant to vancomycin-Pennsylvania, 2002 MMWR 51 2002 902
32. F.C. Tenover L.M. Weigel P.C. Appelbaum et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania Antimicrob Agents Chemother 48 2004 275-280
33. Centers for Disease Control and Prevention Vancomycin-resistant Staphylococcus aureus-New York 2004 MMWR 53 2004 322-323
34. N. Woodford Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci Microb Drug Resist 7 2001 229-236
35. A.R. Brown S.G.B. Amyes R. Paton et al. Epidemiology and control of vancomycin-resistant enterococci (VRE) in a renal unit J Hosp Infect 40 1998 115-124
36. A.H.C. Uttley R.C. George J. Naidoo et al. High level vancomycin-resistant enterococci causing hospital infections Epidemiol Infect 103 1989 173-181
37. G.A. Papanicolaou B.R. Meyers J. et al. Meyers Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: Risk factors for acquisition and mortality Clin Infect Dis 23 1996 760-766
38. S.J. Bradley A.L. Wilson M.C. Allen et al. The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage J Antimicrob Chemother 43 1999 261-266
39. M.B. Edmond J.F. Ober D.L. Weinbaum et al. Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection Clin Infect Dis 20 1995 1126-1133
40. P.R. Chadwick B.A. Oppenheim A. Fox et al. Epidemiology of an outbreak due to gylcopeptide-resistant Enterococcus faecium on a leukemia unit J Hosp Infect 34 1996 171-182
41. K.J. Henning H. Delencastre J. Eagan et al. Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: Duration of stool shedding and incidence of clinical infection Pediatr Infect Dis J 15 1996 848-854
42. L.L. Livornese S. Dias C. Samel et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers Ann Intern Med 117 1992 112-116
43. S. Handwerger B. Raucher D. Altarac et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin Clin Infect Dis 16 1993 750-755
44. W.J. Martone Spread of vancomycin-resistant enterococci: Why did it happen in the United States? Infect Control Hosp Epidemiol 19 1998 539-545
45. M.J.M. Bonten M.K. Hayden C. Nathan et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci Lancet 348 1996 1615-1619
46. L.V. Karanfil M. Murphy A. Josephson et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit Infect Control Hosp Epidemiol 13 1992 195-200
47. J.M. Boyce S.M. Opal J.W. Chow et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance J Clin Microbiol 32 1994 1148-1153
48. H.A. Kirst D.G. Thompson T.I. Nicas Historical yearly usage of vancomycin Antimicrob Agents Chemother 42 1998 1303-1304
49. J.G. Morris Jr D.K. Shay J.N. Hebden et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin: Establishment of endemicity in a university medical center Ann Intern Med 123 1995 250-259
50. L.L. Dever C. China R.H. Eng et al. Vancomycin-resistant Enterococccus faecium in a veterans affairs medical center: Association with antibiotic usage Am J Infect Control 26 1998 40-46
51. G.M. Lucas N. Lechtzin D.W. Puryear et al. Vancomycin-resistant and vancomycin-sensitive enterococcal bacteremia: Comparison of clinical features and outcomes Clin Infect Dis 26 1998 1127-1133
52. S.K. Fridkin R. Lawton J.R. Edwards et al. Monitoring antimicrobial use and resistance: Comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci Emerg Infect Dis 8 2002 702-707
53. Y. Carmeli M.H. Samore W.C. Huskins The association between vancomycin treatment and hospital-acquired vancomycin-resistant enterococci in a medical intensive care unit Ann Intern Med 159 1999 2461-2468
54. Y. Carmeli G.M. Elkiopoulos M.H. Samore Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus Emerg Infect Dis 8 2002 802-807
55. D.N. Gerding Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? Clin Infect Dis 25 Suppl 2 1997 S206-S210
56. J.I. Tokars S. Satake D. Rimland et al. The prevalence of colonization with vancomycin-resistant Enterococcus at a veterans' affairs institution Infect Control Hosp Epidemiol 20 1999 171-175
57. L.G. Rubin V. Tucci E. Cercenado et al. Vancomycin-resistant Enterococcus faecium in hospitalized children Infect Control Hosp Epidemiol 13 1992 700-705
58. N.G. Tornieporth R.B. Roberts J. John et al. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients Clin Infect Dis 23 1996 767-772
59. Centers for Disease Control and Prevention Nosocomial enterococci resistant to vancomycin-United States MMWR 42 1993 597-599
60. J. Bates Epidemiology of vancomycin-resistant enterococci in the community and the relevance of farm animals to human infection J Hosp Infect 37 1997 89-101
61. W. Witte Selective pressure by antibiotic use in livestock Int J Antimicrob Agents 16 Suppl 2000 S19-S24
62. H.P. Endtz N. van den Braak A. van Belkum et al. Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands J Clin Microbiol 35 1997 3026-3031
63. F. Moreno P. Grota C. Crisp et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city of Southern Texas Clin Infect Dis 21 1995 1234-1237
64. S. Slaughter M.K. Hayden C. Nathan et al. A comparison of the effect of universal use of gloves and gown with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit Ann Intern Med 125 1996 448-456
65. D.A. Pegues C.F. Pegues P.L. Hibberd et al. Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital J Clin Microbiol 35 1997 1565-1570
66. A. Berchieri Intestinal colonization of a human subject by vancomycin-resistant Enterococcus faecium Clin Microbiol Infect 5 1999 97-100
67. A.M. Hammerum L.B. Jensen F.M. Aarestrup Detection of the satA gene and transferability of virginiamycin resistance in Enterococcus faecium from food-animals FEMS Microbiol Lett 168 1998 145-151
68. R.J. Willems J. Top N. van den Braak et al. Molecular diversity and evolutionary relationships of Tn1546-like elements in enterococci from humans and animals Antimicrob Agents Chemother 43 1999 483-491
69. T.M. Coque J.F. Tomayko S.C. Ricke et al. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States Antimicrob Agents Chemother 40 1996 2605-2609
70. H. Goossens Spread of vancomycin-resistant enterococci: Differences between United States and Europe Infect Control Hosp Epidemiol 19 1998 546-551
71. M.H. Reacher A. Shah D.M. Livermore et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: Trend analysis BMJ 320 2000 213-216
72. D.M. Hacek P. Bednarz G.A. Noskin et al. Yield of vancomycin-resistant enterococci and multidrug-resistant Enterobacteriaceae from stools submitted for Clostridium difficile testing compared to results from a focused surveillance program J Clin Microbiol 39 2001 1152-1154
73. K.C. Katz M.A. Gardam J. Burt et al. A comparison of multifaceted versus Clostridium difficile-focused VRE surveillance strategies in a low-prevalence setting Infect Control Hosp Epidemiol 22 2001 219-221
74. M.E. Taylor B.A. Oppenheim P.R. Chadwick et al. Detection of glycopeptide-resistant enterococci in routine diagnostic faeces specimens J Hosp Infect 43 1999 25-32
75. J.J. Wade The emergence of Enterococcus faecium resistant to glycopeptides and other standard agents-a preliminary report J Hosp Infect 30 Suppl 1985 S483-S493
76. D.W. Beezhold S. Slaughter M.K. Hayden et al. Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia Clin Infect Dis 24 1997 704-706
77. M. Roghmann S. Qaiyumi J.A. Johnson et al. Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years Clin Infect Dis 24 1997 514-515
78. M.A. Montecalvo D.K. Shay P. Patel et al. Bloodstream infections with vancomycin-resistant enterococci Arch Intern Med 156 1996 1458-1462
79. G.A. Noskin V. Stosor I. Cooper et al. Recovery of vancomycin-resistant enterococci on finger tips and environmental surfaces Infect Control Hosp Epidemiol 16 1995 577-581
80. F.K. Gould R. Freeman Nosocomial infection with microsphere beds Lancet 342 1993 241-242
81. N. Woodford D. Morrison A.P. Johnson et al. Application of DNA probes for rRNA and vanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci J Clin Microbiol 31 1993 653-658
82. C.E. Chenoweth S.F. Bradley M.S. Terpenning et al. Colonization and transmission of high-level gentamicin-resistant enterococci in a long-term care facility Infect Control Hosp Epidemiol 15 1994 703-709
83. C.G. Mayhall The epidemiology and control of VRE: Still struggling to come of age Infect Control Hosp Epidemiol 20 1999 650-652
84. A.E. Van den Bogaard N. Bruinsma E.E. Stobberingh The effect of banning avoparcin on VRE carriage in The Netherlands J Antimicrob Chemother 46 2000 146-147
85. I. Klare D. Badstübner C. Konstabel et al. Decreased incidence of vanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry Microb Drug Resist 5 1999 45-52
86. F.M. Aarestrup A.M. Seyfarth H.D. Emborg et al. Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark Antimicrob Agents Chemother 45 2001 2054-2059
87. R.R. Nelson Selective isolation of vancomycin-resistant enterococci J Hosp Infect 39 1998 13-18
88. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 6th ed 2003 National Committee for Clinical Laboratory Standards Wayne, PA [Approved Standard M7-A5]
89. J.M. Andrews for the BSAC Working Party on Susceptibility Testing BSAC standardized disc susceptibility testing method J Antimicrob Chemother 48 Suppl 1 2001 S43-S57
90. M.D. Ford J.D. Perry F.K. Gould et al. Neomycin blood agar as a selective medium for vancomycin-resistant Enterococcus faecium J Clin Pathol 49 1996 437
91. M. Ieven E. Vercauteren P. Descheemaeker et al. Comparison of direct plating and broth enrichment culture for the detection of intestinal colonization by glycopeptide-resistant enterococci among hospitalized patients J Clin Microbiol 37 1999 1436-1440
92. Morrison D. Evaluation of DNA typing methods for Enterococcus faecium. PhD Thesis. University of London; 1999.
93. D. Morrison N. Woodford B. Cookson Enterococci as emerging pathogens of humans J Appl Microbiol 83 Suppl 1997 S89-S99
94. K. Borgen Y. Wasteson H. Kruse et al. Vancomycin-resistant Enterococcus faecium (VREF) from Norwegian poultry cluster with VREF from poultry from the United Kingdom and The Netherlands in an amplified fragment length polymorphism genogroup Appl Environ Microbiol 68 2002 3133-3137
95. W.L. Homan D. Tribe S. Poznanski et al. Multilocus sequence typing scheme for Enterococcus faecium J Clin Microbiol 40 2002 1963-1971
96. R.V. Goering Molecular epidemiology of nosocomial infection: Analysis of chromosomal restriction fragment patterns by pulsed-field gel electrophoresis Infect Control Hosp Epidemiol 14 1993 595-600
97. F.C. Tenover R.D. Arbeit R.V. Goering et al. Interpreting chromosomal DNA restriction patterns producd by pulsed-field gel electrophoresis: criteria for bacterial strain typing J Clin Microbiol 33 1995 2233-2239
98. T.R. Frieden S.S. Munsiff D.E. Low et al. Emergence of vancomycin-resistant enterococci in New York city Lancet 342 1993 76-79
99. N. Woodford A.M. Adebiyi M.F. Palepou et al. Diversity of vanA glycopeptide resistance elements in enterococci from humans and nonhuman sources Antimicrob Agents Chemother 42 1998 502-508
100. D. Morrison N. Woodford S.P. Barrett et al. DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains J Clin Microbiol 37 1999 1084-1091
101. R.J. Willems W. Homan J. Top et al. Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals Lancet 357 2001 853-855
102. N. Woodford M. Soltani K.J. Hardy Frequency of esp in Enterococcus faecium isolates Lancet 358 2001 584
103. B.E. Murray Vancomycin-resistant enterococcal infections N Engl J Med 342 2000 710-721
104. G.M. Elliopoulos Quinupristin-dalfopristin and linezolid: Evidence and opinion Clin Infect Dis 36 2003 473-481
105. R.D. Gonzales P.C. Schreckenberger M.B. Graham et al. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid Lancet 357 2001 1179
106. J.K.S. Chia M.M. Nakata S.S. Park et al. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium Clin Infect Dis 21 1995 1520
107. M.S. Whitman P.G. Pitsakis E. DeJesus et al. Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model Antimicrob Agents Chemother 40 1996 1526-1530
108. M.R. Weinstein H. Dedier J. Brunton et al. Lack of efficacy of oral bacitracin plus deoxycyline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium Clin Infect Dis 29 1999 361-366
109. I.C. Bowler J.A. Storr G.J. Davies et al. Guidelines for the management of patients colonized or infected with vancomycin-resistant enterococci J Hosp Infect 39 1998 75-77
110. V. Stosor L.R. Peterson M. Postelnick et al. Enterococcus faecium bacteremia Arch Intern Med 158 1998 522-527
111. B. Ridwan E. Mascini N. van der Reijden et al. What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals BMJ 324 2002 666-668
112. B. Cookson Glycopeptide resistant enterococci in European hospitals Eurosurveillance Weekly 6 12 2002
113. G.C. Mayhall Control of vancomycin-resistant enterococci: It is important, it is possible, and it is cost effective Infect Control Hosp Epidemiol 23 2002 420-423
114. K.M. McCarthy W. Van Nierop A. Duse et al. Control of an outbreak of vancomycin-resistant Enterococcus faecium in an oncology ward in South Africa: Effective use of limited resources J Hosp Infect 44 2000 294-300
115. R.G. Masterton A.J. Mifsud G.G. Rao Review of hospital isolation and infection control precautions J Hosp Infect 54 2003 171-173
116. G.G. Rao A. Jeanes A pragmatic approach to the use of isolation facilities Bugs Drugs 5 1999 4-6
117. D. Pittet S. Hugonnet S. Harbarth et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme Lancet 356 2000 1307-1312
118. S.P. Stone L. Teare B.D. Cookson The evidence for hand-hygiene Lancet 357 2001 479-480
119. D.J. Austin M.J. Bonten R.A. Weinstein et al. Vancomycin-resistant enterococci in intensive-care hospital settings: Transmission dynamics, persistence, and the impact of infection control programs Proc Natl Acad Sci 96 1999 6908-6913
120. J.J. Wade N. Desai M.W. Casewell Hygienic hand disinfection for the removal of epidemic vancomycin-resistant Enterococcus faecium and gentamicin-resistant Enterobacter cloacae J Hosp Infect 18 1991 211-218
121. H. Kjolen B.M. Andersen Handwashing and disinfection of heavily contaminated hands-effective or ineffective? J Hosp Infect 21 1992 61-71
122. B.N. Doebbeling G.L. Stanley C.T. Sheetz et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units N Engl J Med 327 1992 88-93
123. G. Nicoletti V. Boghossian R. Borland Hygienic hand disinfection: A comparative study with chlorhexidine detergents and soap J Hosp Infect 15 1990 323-337
124. E.L. Larson APIC guideline for handwashing and hand antisepsis in health care settings Am J Infect Control 23 1995 251-269
125. A. Voss A.F. Widmer No time for handwashing!? Handwashing versus alcoholic rub: Can we afford 100% compliance? Infect Control Hosp Epidemiol 18 1997 205-208
126. B. Cookson L. Teare D. May et al. Draft hand hygiene standards J Hosp Infect 49 2001 153 [Finalized standards announcement in J Hosp Infect 2001;53:83]
127. G.A. Ayliffe E.J. Lowbury A.M. Geddes Control of hospital infection 1992 Chapman&Hall London
128. NHS Estates Standards for environmental cleanliness in hospitals 2000 Department of Health London
129. A.P. Fraise The treatment and control of vancomycin resistant enterococci J Antimicrob Chemother 38 1996 753-756
130. G. Saurina D. Landman J.M. Quale Activity of disinfectants against vancomycin-resistant Enterococcus faecium Infect Control Hosp Epidemiol 18 1997 345-347
131. Y. Sakagami K. Kajimura Bactericidal activities of disinfectants against vancomycin-resistant enterococci J Hosp Infect 50 2002 140-144
132. Standing Medical Advisory Committee The path of least resistance 1999 Department of Health London
133. N.A. Simmons BSAC Endocarditis Working Party Recommendations for endocarditis prophylaxis J Antimicrob Chemother 31 1993 437-438